LAUREL HOUSE SURGERY — All Prescriptions & Medications — Page 12
Practice Code: M83062 | TAMWORTH, B79 7JN
Showing results 551-600 of 677
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Losartan potassium with diuretic | 16 | 784 | £93 | -37.6% ▼ |
| Dexamethasone | 16 | 2,347 | £550 | -48.7% ▼ |
| Mercaptopurine | 16 | 800 | £374 | +3.3% ▲ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 16 | 206.4K | £2.9K | +50.0% ▲ |
| 16 | 192 | £102 | -56.8% ▼ | |
| 16 | 245 | £170 | +34.2% ▲ | |
| 16 | 170 | £468 | +166.3% ▲ | |
| 16 | 110 | £259 | +9.6% ▲ | |
| 16 | 1,560 | £4.9K | -28.6% ▼ | |
| 16 | 360 | £1.8K | +26.5% ▲ | |
| 16 | 480 | £2.1K | +30.5% ▲ | |
| 16 | 860 | £1.2K | +25.6% ▲ | |
| Lurasidone | 15 | 420 | £1.1K | -39.9% ▼ |
| Darifenacin hydrobromide | 15 | 420 | £384 | -54.0% ▼ |
| Ready to serve 1.5 kcal/ml milkshake with fibre (0913021) | 15 | 325.8K | £8.6K | +8.6% ▲ |
| Phenazone/lidocaine | 15 | 225 | £127 | +46.7% ▲ |
| Hydrocortisone acetate | 15 | 160 | £506 | +126.9% ▲ |
| Clindamycin phosphate | 15 | 630 | £152 | -8.8% ▼ |
| Aciclovir | 15 | 198 | £188 | +21.7% ▲ |
| 15 | 380 | £591 | -61.9% ▼ | |
| 15 | 425 | £1.4K | +26.5% ▲ | |
| 15 | 55 | £2.2K | +65.3% ▲ | |
| 15 | 44 | £2.2K | +108.3% ▲ | |
| 15 | 350 | £300 | -42.4% ▼ | |
| 15 | 590 | £3.0K | -32.8% ▼ | |
| 15 | 580 | £3.0K | +77.7% ▲ | |
| Sodium citrate (Rectal) | 14 | 153 | £103 | +1.5% vs avg |
| Buspirone hydrochloride | 14 | 840 | £121 | -72.2% ▼ |
| Itraconazole | 14 | 766 | £393 | +4.4% ▲ |
| Propylthiouracil | 14 | 2,016 | £196 | +11.4% ▲ |
| Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | 14 | 476 | £260 | -45.5% ▼ |
| RtS 1.4-1.5kcal/ml energy & higher protein liquid (0913141) | 14 | 698 | £1.6K | +44.4% ▲ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 14 | 35.7K | £1.1K | -47.3% ▼ |
| Tizanidine hydrochloride | 14 | 1,778 | £76 | -47.1% ▼ |
| Fusidic acid | 14 | 75 | £278 | +35.5% ▲ |
| Bromfenac | 14 | 70 | £113 | +194.4% ▲ |
| 14 | 14 | £365 | +63.0% ▲ | |
| 14 | 14 | £674 | +258.4% ▲ | |
| 14 | 26 | £1.4K | +213.9% ▲ | |
| 14 | 9,322 | £449 | +72.8% ▲ | |
| 14 | 2,400 | £849 | +99.5% ▲ | |
| 14 | 810 | £473 | -65.8% ▼ | |
| 14 | 280 | £1.1K | -25.0% ▼ | |
| Zinc oxide | 13 | 344 | £39 | -37.2% ▼ |
| Co-amilozide (Amiloride hydrochloride/hydrochlorothiazide) | 13 | 728 | £332 | -20.5% ▼ |
| Celiprolol hydrochloride | 13 | 728 | £450 | -1.7% vs avg |
| Acrivastine | 13 | 948 | £277 | +5.5% ▲ |
| Flupentixol hydrochloride | 13 | 780 | £60 | -60.3% ▼ |
| Tolbutamide | 13 | 728 | £2.2K | +2.4% ▲ |
| Saxagliptin | 13 | 532 | £571 | -61.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.